Pear Therapeutics (PEAR) Institutional Ownership

Institutional Ownership Changes (13F Filings) for Pear Therapeutics (NASDAQ:PEAR)

Current
Institutional Ownership
Percentage
71.17%
Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$2.77M
Number of
Institutional Sellers
(last 12 months)
0
Get PEAR Insider Trade Alerts

Want to know when executives and insiders are buying or selling Pear Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

PEAR Institutional Buying and Selling by Quarter

Pear Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/2/2023Arboretum Ventures LLC10,859,050$2.77M8.2%N/A7.608%
3/23/2023MetLife Investment Management LLC41,941$49K0.0%N/A0.030%
2/13/2023The Manufacturers Life Insurance Company29,233$34K0.0%N/A0.021%
2/2/2023SG Americas Securities LLC25,676$30K0.0%+61.1%0.018%
1/24/2023Darrow Company Inc.154,711$183K0.2%-15.1%0.110%
11/15/2022Verdence Capital Advisors LLC13,815$28K0.0%N/A0.010%
11/8/2022New York State Common Retirement Fund48,590$99K0.0%N/A0.035%
11/3/2022Darrow Company Inc.182,211$371K0.4%N/A0.131%
11/2/2022Daiwa Securities Group Inc.12,737$26K0.0%N/A0.009%
10/31/2022SG Americas Securities LLC15,935$33K0.0%N/A0.011%
10/27/2022US Bancorp DE54,897$112K0.0%N/A0.040%
10/27/2022Strs Ohio15,900$32K0.0%N/A0.011%
10/12/2022 Acropolis Investment Management LLC164,842$336K0.0%N/A0.119%
5/12/2022Magnus Financial Group LLC11,800$60K0.0%N/A0.009%
5/11/2022GSA Capital Partners LLP28,900$146K0.0%N/A0.021%
4/26/2022Sciencast Management LP36,621$190K0.0%N/A0.027%
2/25/2022 EDBI Pte Ltd426,371$2.64M1.4%N/A1.236%
2/14/2022Sarissa Capital Management LP500,356$3.10M0.3%N/A1.450%
2/14/2022SB Global Advisers Ltd12,100,078$75.02M1.5%N/A35.073%
2/9/2022Arboretum Ventures Inc.10,859,050$67.33M38.8%N/A31.476%
2/7/2022 Roble Belko & Company Inc4,502$28K0.0%N/A0.013%
2/3/20225AM Venture Management LLC18,631,771$115.52M21.7%N/A54.005%
1/28/2022BerganKDV Wealth Management LLC4,500$28K0.0%N/A0.013%
1/18/2022 TB Alternative Assets Ltd.2,071,865$12.85M3.8%N/A25.233%
(Data available from 1/1/2016 forward)

PEAR Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of PEAR shares?

During the previous two years, 13 institutional investors and hedge funds held shares of Pear Therapeutics. The most heavily invested institutionals were Arboretum Ventures LLC ($2.77M), Acropolis Investment Management LLC ($336K), Darrow Company Inc. ($183K), GSA Capital Partners LLP ($146K), US Bancorp DE ($112K), New York State Common Retirement Fund ($99K), and Magnus Financial Group LLC ($60K).Learn more on PEAR's institutional investors.

What percentage of Pear Therapeutics stock is owned by institutional investors?

71.17% of Pear Therapeutics stock is owned by institutional investors. Learn more on PEAR's institutional investor holdings.

Which institutional investors have been buying Pear Therapeutics stock?

Of the 13 institutional investors that purchased Pear Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Arboretum Ventures LLC ($10.86M), Darrow Company Inc. ($182.21K), Acropolis Investment Management LLC ($164.84K), US Bancorp DE ($54.90K), New York State Common Retirement Fund ($48.59K), MetLife Investment Management LLC ($41.94K), and The Manufacturers Life Insurance Company ($29.23K).

How much institutional buying is happening at Pear Therapeutics?

Institutional investors have bought a total of 11,489,592 shares in the last 24 months. This purchase volume represents approximately $4.11M in transactions.

Which Pear Therapeutics major shareholders have been selling company stock?

The following institutional investors have sold Pear Therapeutics stock in the last 24 months: Darrow Company Inc. ($27.50K).

How much institutional selling is happening at Pear Therapeutics?

Institutional investors have sold a total of 27,500 shares in the last 24 months. This volume of shares sold represents approximately $32.45K in transactions.


This page (NASDAQ:PEAR) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners